Shattuck Labs

NEWS

Hand holding pencil erasing an employee. Dismissal or bankrumptcy concept. Vector illustration.

Layoffs

Shattuck Labs to Lay Off 40% of Workforce

As it shifts focus to a death receptor 3 (DR3) antagonist antibody, Shattuck Labs is cutting a significant number of employees before the end of the year.

October 1, 2024

2 min read

Angela Gabriel

Deals

4 Biotech IPOs this Week: Kronos, Shattuck, Spruce and Aziyo

It’s been a fairly busy week for biotech initial public offerings (IPOs) with four announcing their list pricing. Here’s a look.

October 9, 2020

4 min read

Mark Terry

JOBS

IN THE PRESS

Bio NC

Shattuck Labs Announces Participation in Upcoming 11th Annual SVB Leerink Global Healthcare Conference

February 9, 2022

1 min read

Bio NC

Shattuck Labs Announces Participation in Upcoming January Investor Conferences

January 5, 2022

2 min read

Bio NC

Shattuck Labs to Present at TIGIT Therapies Digital Summit 2021

December 2, 2021

1 min read

Business

Shattuck Labs Reports Third Quarter 2021 Financial Results and Recent Business Highlights

November 9, 2021

15 min read

Drug Development

Shattuck Labs Announces Preliminary Clinical Data from Ongoing Phase 1 Clinical Trials of ARC Fusion Proteins SL-172154 and SL-279252

November 9, 2021

10 min read

Bio NC

Shattuck Labs to Host Conference Call and Webcast Highlighting Data Presented at the 2021 Society for Immunotherapy of Cancer (SITC) Annual Meeting

November 4, 2021

2 min read

Bio NC

Shattuck Labs Announces Participation in Upcoming November Investor Conferences

November 3, 2021

2 min read

Business

Shattuck Labs Announces Changes to its Board of Directors

October 28, 2021

5 min read

Bio NC

Shattuck Labs to Present Clinical Data on SL-172154 and SL-279252 and Preclinical Data on SL-9258 at the 2021 Society for Immunotherapy of Cancer (SITC) Annual Meeting

October 1, 2021

2 min read

Bio NC

Shattuck Labs Announces Participation in Upcoming September Conferences

September 1, 2021

2 min read